# Audit: statusEpilepticus.ts

**Severity: NONE (no definite errors found).**

## What was checked and confirmed correct
32M, known seizure disorder, missed medication for 4 days, continuous generalised tonic-clonic activity >20 minutes with no recovery of awareness between events — an unambiguous convulsive status epilepticus presentation with no contradictions between vitals, exam and diagnosis (tachycardia, mild hypertension and mild fever are all explained as the expected autonomic/muscular consequence of ongoing convulsions, not miscoded as a separate diagnosis).

- **Timing matches the AES 2016 status epilepticus treatment algorithm**: benzodiazepine targeted at 5 minutes (stabilisation/initial-therapy phase), second-line IV agent (levetiracetam or phenytoin) targeted at 20 minutes (the 20–40 minute second-therapy window) — both `criticalInterventions` targets are consistent with the real guideline's time windows, not arbitrary numbers.
- `levetiracetam` and `phenytoin` both correctly `requiresFirst: ['lorazepam']`, with an accurate harmful-sequence rationale ("giving a second-line agent before a benzodiazepine wastes the window in which seizures are most easily terminated") — matches the core teaching point the case is built around.
- Phenytoin rationale correctly states the maximum infusion rate (~50 mg/min) and the incompatibility with dextrose-containing fluid (precipitation) — both standard, correctly stated facts.
- Nifedipine (oral, for the elevated BP) correctly graded **harmful**: the hypertension here is a compensatory autonomic response to ongoing convulsive activity that resolves once the seizure is controlled, and abruptly lowering it risks cerebral hypoperfusion — correct and a genuinely useful teaching point, since treating the "vital sign" instead of the seizure is a realistic trap.
- Bedside glucose (GRBS) is correctly framed as mandatory in every convulsing patient regardless of a normal result, and dextrose/thiamine are correctly graded neutral (no indication here, but not wrong to consider) rather than indicated or harmful.
- ABG (pH 7.28, PaCO2 44, HCO3 20) and serum lactate (6.2 mmol/L) are correctly interpreted as an expected transient lactic/respiratory acidosis from prolonged muscular activity that should resolve once convulsions stop, not miscoded as a sepsis or primary metabolic picture — consistent with the stress leukocytosis (WBC 13,200) also being correctly attributed to muscular activity rather than infection.
- CT head correctly ordered and reported as unremarkable (appropriate first-line imaging to exclude a structural cause after stabilisation); MRI brain correctly marked non-indicative (not necessary for this acute presentation); troponin correctly marked non-indicative in the absence of chest pain or ECG changes.

## Minor observation (not a factual error)
`nifedipine` is described as given orally to a patient stated to be actively, continuously convulsing and unresponsive throughout ("unresponsive to voice throughout the limb jerking"). Administering any oral medication to a patient who is actively seizing is itself unsafe (aspiration risk) independent of the blood-pressure-lowering harm the case already scores it for. This does not change the case's grading (nifedipine is already correctly marked harmful) and is a scenario-realism nitpick rather than a clinical-fact error, so it is not counted as a definite error.

## Sources consulted
- AES 2016 status epilepticus treatment algorithm / ESETT trial time windows (benzodiazepine first-line within minutes, second-line IV anti-seizure medication in the 20–40 minute window) — domain knowledge, cross-checked against the case's own stated target times and found consistent; the values here are unambiguous well-established teaching, so no web search was needed.
- Phenytoin maximum infusion rate and dextrose incompatibility, autonomic/lactic-acidosis physiology of prolonged convulsions — domain knowledge, internally consistent with the case's own numbers.
